Post-stroke depression: Mechanisms and pharmacological treatment
Tóm tắt
Từ khóa
Tài liệu tham khảo
Acler, 2009, A double blind placebo RCT to investigate the effects of serotoninergic modulation on brain excitability and motor recovery in stroke patients, Journal of Neurology, 256, 1152, 10.1007/s00415-009-5093-7
Adada, 2016, Inhibitors of the sphingomyeline cycle: Sphingomyelin synthases and sphingomyelinases, Chemistry and Physics of Lipids, 197, 45, 10.1016/j.chemphyslip.2015.07.008
Adzic, 2016, Antidepressant action on mitochondrial dysfunction in psychiatric disorders, Drug Development Research, 77, 400, 10.1002/ddr.21332
Allen, 2009, Oxidative stress and its role in the pathogenesis of ischaemic stroke, International Journal of Stroke, 4, 461, 10.1111/j.1747-4949.2009.00387.x
Åström, 1993, Different linkage of depression to hypercortisolism early versus late after stroke. A 3-year longitudinal study, Stroke, 24, 52, 10.1161/01.STR.24.1.52
Ayerbe, 2014, The long-term outcomes of depression up to 10years after stroke; the South London Stroke Register, Journal of Neurology, Neurosurgery, and Psychiatry, 85, 514, 10.1136/jnnp-2013-306448
Ayerbe, 2013, Natural history, predictors and outcomes of depression after stroke: Systematic review and meta-analysis, The British Journal of Psychiatry, 202, 14, 10.1192/bjp.bp.111.107664
Bansal, 2016, Mitochondrial dysfunction in depression, Current Neuropharmacology, 14, 610, 10.2174/1570159X14666160229114755
Bartoli, 2013, Depression after stroke and risk of mortality: A systematic review and meta-analysis, Stroke Research and Treatment, 2013, 862978, 10.1155/2013/862978
Barugh, 2014, Cortisol levels and the severity and outcomes of acute stroke: A systematic review, Journal of Neurology, 261, 533, 10.1007/s00415-013-7231-5
Baune, 2017, Are non-steroidal anti-inflammatory drugs clinically suitable for the treatment of symptoms in depression-associated inflammation?, Current Topics in Behavioral Neurosciences, 31, 303, 10.1007/7854_2016_19
Berg, 2009, Assessment of depression after stroke: A comparison of different screening instruments, Stroke, 40, 523, 10.1161/STROKEAHA.108.527705
Biffi, 2017, Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: A meta-analysis of observational studies, European Journal of Clinical Pharmacology, 73, 487, 10.1007/s00228-016-2187-x
Bonita, 1997, Prevalence of stroke and stroke-related disability. Estimates from the Auckland stroke studies, Stroke, 28, 1898, 10.1161/01.STR.28.10.1898
Bos, 2008, Depressive symptoms and the risk of stroke: The Rotterdam study, Journal of Neurology, Neurosurgery, and Psychiatry, 79, 997, 10.1136/jnnp.2007.134965
Bowen, 2005, Psychological services for people with stroke: Compliance with the U.K. National Clinical Guidelines, Clinical Rehabilitation, 19, 323, 10.1191/0269215505cr799oa
Brunner, 2014, Depressive disorders, coronary heart disease, and stroke: Dose-response and reverse causation effects in the Whitehall II cohort study, European Journal of Preventive Cardiology, 21, 340, 10.1177/2047487314520785
Bryer, 1992, Reduction of CSF monoamine metabolite in poststroke depression: A preliminary report, The Journal of Neuropsychiatry and Clinical Neurosciences, 4, 440, 10.1176/jnp.4.4.440
Burkhalter, 2003, Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons, The Journal of Neuroscience, 23, 8212, 10.1523/JNEUROSCI.23-23-08212.2003
Burns, 2010, Antidepressants in the treatment of stroke, Expert Review of Neurotherapeutics, 10, 1237, 10.1586/ern.10.96
Chen, 2001, Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication, Biological Psychiatry, 50, 260, 10.1016/S0006-3223(01)01083-6
Chen, 2006, Treatment effects of antidepressants in patients with post-stroke depression: A meta-analysis, The Annals of Pharmacotherapy, 40, 2115, 10.1345/aph.1H389
Chen, 2007, Antidepressant prophylaxis for poststroke depression: A meta-analysis, International Clinical Psychopharmacology, 22, 159, 10.1097/YIC.0b013e32807fb028
Chen, 2015, Overexpression of brain-derived neurotrophic factor in the hippocampus protects against post-stroke depression, Neural Regeneration Research, 10, 1427, 10.4103/1673-5374.165510
Cheng, 2014, Plasma levels of glutamate during stroke is associated with development of post-stroke depression, Psychoneuroendocrinology, 47, 126, 10.1016/j.psyneuen.2014.05.006
Choi, 2009, The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: Implications for translational research, Trends in Pharmacological Sciences, 30, 174, 10.1016/j.tips.2009.01.002
Chollet, 2012, Selective serotonin reuptake inhibitors may be helpful in most patients with stroke, Stroke, 43, 3150, 10.1161/STROKEAHA.112.657619
Chollet, 2011, Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebo-controlled trial, Lancet Neurology, 10, 123, 10.1016/S1474-4422(10)70314-8
Cipriani, 2009, Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis, Lancet, 373, 746, 10.1016/S0140-6736(09)60046-5
Coupland, 2011, Antidepressant use and the risk of adverse outcomes in older people: Population based cohort study, BMJ, 343, d4551, 10.1136/bmj.d4551
De Rick, 2014, Risk factors for poststroke depression: Identification of inconsistencies based on a systematic review, Journal of Geriatric Psychiatry and Neurology, 27, 147, 10.1177/0891988714527514
De Ryck, 2013, A prospective study on the prevalence and risk factors of post-stroke depression, Cerebrovascular Diseases Extra, 3, 1, 10.1159/000345557
Dong, 2012, Depression and the risk of stroke. A meta-analysis of prospective studies, Stroke, 43, 32, 10.1161/STROKEAHA.111.630871
Drevets, 2000, Neuroimaging studies of mood disorders, Biological Psychiatry, 48, 813, 10.1016/S0006-3223(00)01020-9
Espinera, 2013, Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice, Neuroscience, 247, 1, 10.1016/j.neuroscience.2013.04.011
Feigin, 2014, Global and regional burden of stroke during 1990–2010: Findings from the Global Burden of Disease Study 2010, Lancet, 383, 245, 10.1016/S0140-6736(13)61953-4
Ferrarese, 1999, Increased cytokine release from peripheral blood cells after acute stroke, Journal of Cerebral Blood Flow and Metabolism, 19, 1004, 10.1097/00004647-199909000-00008
Ferrari, 2016, Bioenergetic characterization of lymphocytes from stroke patients, Cerebrovascular Diseases, 41, S4
Ferrari, 2017, The neurobiology of depression: An integrated overview from biological theories to clinical evidence, Molecular Neurobiology, 54, 4847, 10.1007/s12035-016-0032-y
Figlewicz, 1999, Endocrine regulation of neurotransmitter transporters, Epilepsy Research, 37, 203, 10.1016/S0920-1211(99)00072-8
Filipovic, 2017, Chronic fluoxetine treatment directs energy metabolism towards the citric acid and oxidative phosphorylation in rat hippocampal nonsynaptic mitochondria, Brain Research, 1659, 41, 10.1016/j.brainres.2017.01.025
Flaster, 2013, Poststroke depression: A review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery, Topics in Stroke Rehabilitation, 20, 139, 10.1310/tsr2002-139
Gao, 2017, Different intervention for post-ischaemic stroke depression in different time periods: A single-blind randomized controlled trial with stratification by time after stroke, Clinical Rehabilitation, 31, 71, 10.1177/0269215515626232
Gardner, 2011, Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 730, 10.1016/j.pnpbp.2010.07.030
Gaynor, 2011, A randomized placebo-controlled trial of duloxetine in patients with major depressive disorders and associated painful physical symptoms, Current Medical Research and Opinion, 27, 1849, 10.1185/03007995.2011.609539
Gilsanz, 2015, Changes in depressive symptoms and incidence of first stroke among middle-aged and older US adults, Journal of the American Heart Association, 4, 10.1161/JAHA.115.001923
Glodzik-Sobanska, 2006, Single voxel proton magnetic resonance spectroscopy in post-stroke depression, Psychiatry Research, 148, 111, 10.1016/j.pscychresns.2006.08.004
Go, 2013, Heart disease and stroke statistics-2014 update. A report from the American Heart Association, Circulation, 129, e28
Gotlib, 2008, HPA-Axis reactivity: A mechanism underlying the association among 5-HTTLPR, stress, and depression, Biological Psychiatry, 63, 847, 10.1016/j.biopsych.2007.10.008
Gulbins, 2013, Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs, Nature Medicine, 19, 934, 10.1038/nm.3214
Gulbins, 2015, A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression, Journal of Neurochemistry, 134, 183, 10.1111/jnc.13145
Hackam, 2012, Selective serotonin reuptake inhibitors and brain hemorrhage. A meta-analysis, Neurology, 79, 1862, 10.1212/WNL.0b013e318271f848
Hackett, 2005, Predictors of depression after stroke: A systematic review of observational studies, Stroke, 36, 2296, 10.1161/01.STR.0000183622.75135.a4
Hackett, 2014, Part I: Frequency of depression after stroke: An updated systematic review and meta-analysis of observational studies, International Journal of Stroke, 9, 1017, 10.1111/ijs.12357
Hamano, 2015, Depression, stroke and gender: Evidence of a stronger association in men, Journal of Neurology, Neurosurgery, and Psychiatry, 86, 319, 10.1136/jnnp-2014-307616
Hannestad, 2011, The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: A meta-analysis, Neuropsychopharmacology, 36, 2452, 10.1038/npp.2011.132
Harper, 2017, Tissue type-specific bioenergetic abnormalities in adults with major depression, Neuropsychopharmacology, 42, 876, 10.1038/npp.2016.180
Hayhow, 2014, Post-stroke depression, 227
Hoirisch-Clapauch, 2014, Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?, Thrombosis Research, 134, 11, 10.1016/j.thromres.2014.02.028
Husaini, 2013, Depression increases stroke hospitalization cost: An analysis of 17,010 stroke patients in 2008 by race and gender, Stroke Research and Treatment, 2013, 846732, 10.1155/2013/846732
Iadecola, 2011, The immunology of stroke: From mechanisms to translation, Nature Medicine, 17, 796, 10.1038/nm.2399
Jackson, 2013, Depression and risk of stroke in midaged women: A prospective longitudinal study, Stroke, 44, 1555, 10.1161/STROKEAHA.113.001147
Jawaid, 2016, A macro role for microglia in post-stroke depression, Journal of the American Geriatrics Society, 64, 459, 10.1111/jgs.13974
Jorge, 2010, Escitalopram and enhancement of cognitive recovery following stroke, Archives of General Psychiatry, 67, 187, 10.1001/archgenpsychiatry.2009.185
Kappelmann, 2016, Antidepressant activity of anti-cytokine treatment: A systematic review and meta-analysis of clinical trials of chronic inflammatory conditions, Molecular Psychiatry
Karamchandani, 2015, Early depression screening is feasible in hospitalized stroke patients, PLoS One, 10, 10.1371/journal.pone.0128246
Kim, 2015, Studies on the animal model of post-stroke depression and application of antipsychotic aripiprazole, Behavioural Brain Research, 287, 294, 10.1016/j.bbr.2015.03.062
Kim, 2017, Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: A multicentre, double-blind, randomised, placebo-controlled study, The Lancet Psychiatry, 4, 33, 10.1016/S2215-0366(16)30417-5
Kim, 2012, Serotoninergic and BDNF genes and risk of depression after stroke, Journal of Affective Disorders, 136, 833, 10.1016/j.jad.2011.09.029
Klinedinst, 2015, A mitochondrial bioenergetic basis of depression, Journal of Bioenergetics and Biomembranes, 47, 155, 10.1007/s10863-014-9584-6
Köhler, 2016, Inflammation in depression and the potential for anti-inflammatory treatment, Current Neuropharmacology, 14, 732, 10.2174/1570159X14666151208113700
Kölzer, 2004, Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine, FEBS Letters, 559, 96, 10.1016/S0014-5793(04)00033-X
Kornhuber, 2013, Functional inhibitors of sphingomyelinase (FIASMAs), Handbook of Experimental Pharmacology, 215, 169, 10.1007/978-3-7091-1368-4_9
Kronenberg, 2014, Of mice and men: Modelling post-stroke depression experimentally, British Journal of Pharmacology, 171, 4673, 10.1111/bph.12775
Kutlubaev, 2014, Part II: Predictors of depression after stroke and impact of depression on stroke outcome: An updated systematic review of observational studies, International Journal of Stroke, 9, 1026, 10.1111/ijs.12356
Lee, 2013, Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events, Journal of Clinical Psychopharmacology, 33, 782, 10.1097/JCP.0b013e31829c970e
Lee, 2016, Comparison of the effects of serotonin-norepinephrine reuptake inhibitors versus selective serotonin reuptake inhibitors on cerebrovascular events, The Journal of Clinical Psychiatry, 77, e1, 10.4088/JCP.14m09394
Lee, 2011, Pre- and post-treatments with escitalopram protect against experimental ischemic neuronal damage via regulation of BDNF expression and oxidative stress, Experimental Neurology, 229, 450, 10.1016/j.expneurol.2011.03.015
Li, 2009, Chronic fluoxetine treatment improves ischemia-induced spatial cognitive deficits through increasing hippocampal neurogenesis after stroke, Journal of Neuroscience Research, 87, 112, 10.1002/jnr.21829
Li, 2014, Systematic hypothesis for post-stroke depression caused inflammation and neurotransmission and resultant on possible treatments, Neuroendocrinology Letters, 35, 104
Li, 2014, Serum Brain-derived neurotrophic factor levels in post-stroke depression, Journal of Affective Disorders, 168, 373, 10.1016/j.jad.2014.07.011
Lim, 2009, Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect, Journal of Neuroscience Research, 87, 1037, 10.1002/jnr.21899
Loubinoux, 2012, Post-stroke depression: Mechanisms, translation and therapy, Journal of Cellular and Molecular Medicine, 16, 1961, 10.1111/j.1582-4934.2012.01555.x
Ma, 2015, Neuroprotective effect of escitalopram oxalate in rats with chronic hypoperfusion, Journal of Huazhong University of Science and Technology. Medical Sciences, 35, 514, 10.1007/s11596-015-1462-x
Maes, 2011, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 702, 10.1016/j.pnpbp.2010.12.017
Majed, 2012, Depressive symptoms, a time-dependent risk factors for coronary heart disease and stroke in middle-aged men. The PRIME study, Stroke, 43, 1761, 10.1161/STROKEAHA.111.645366
Mak, 2013, Polymorphisms of the serotonin transporter gene and post-stroke depression: A meta-analysis, Journal of Neurology, Neurosurgery, and Psychiatry, 84, 322, 10.1136/jnnp-2012-303791
Mandrioli, 2012, Selective serotonin reuptake inhibitors (SSRIs): Therapeutic drug monitoring and pharmacological interactions, Current Medicinal Chemistry, 19, 1846, 10.2174/092986712800099749
Marshall, 2012, Should every patient with stroke be on selective serotonin reuptake inhibitors? No, Stroke, 43, 3152, 10.1161/STROKEAHA.112.657627
Masi, 2011, The hippocampus, neurotrophic factors and depression, CNS Drugs, 25, 913, 10.2165/11595900-000000000-00000
Mayberg, 1988, PET imaging of cortical S2 serotonin receptors after stroke: Lateralized changes and relationship to depression, The American Journal of Psychiatry, 145, 937, 10.1176/ajp.145.8.937
McCann, 2014, Efficacy of antidepressants in animal models of ischemic stroke. A systematic review and meta-analysis, Stroke, 45, 3055, 10.1161/STROKEAHA.114.006304
McColl, 2009, Systemic infection, inflammation and acute ischemic stroke, Neuroscience, 158, 1049, 10.1016/j.neuroscience.2008.08.019
Mead, 2013, Selective serotonin reuptake inhibitors for stroke recovery — A systematic review and meta-analysis, Stroke, 44, 844, 10.1161/STROKEAHA.112.673947
Meng, 2012, Depression increases the risk of hypertension incidence: A meta-analysis of prospective cohort studies, Journal of Hypertension, 30, 842, 10.1097/HJH.0b013e32835080b7
Miedema, 2010, Effect of selective serotonin re-uptake inhibitors (SSRIs) on functional outcome in patients with acute ischemic stroke treated with tPA, Journal of the Neurological Sciences, 293, 65, 10.1016/j.jns.2010.03.004
Mikami, 2011, Effect of antidepressants on the course of disability following stroke, The American Journal of Geriatric Psychiatry, 19, 1007, 10.1097/JGP.0b013e31821181b0
Mitchell, 2017, Prevalence and predictors of post-stoke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder, General Hospital Psychiatry, 47, 48, 10.1016/j.genhosppsych.2017.04.001
Møller, 2007, Serotonin 5HT1A receptor availability and pathological crying after stroke, Acta Neurologica Scandinavica, 116, 83.90, 10.1111/j.1600-0404.2007.00869.x
Moretti, 2015, Pharmacological therapy of acute ischaemic stroke: Achievements and problems, Pharmacology & Therapeutics, 153, 79, 10.1016/j.pharmthera.2015.06.004
Moretti, 2015, Neuroprotection for ischaemic stroke: Current status and challenges, Pharmacology & Therapeutics, 146, 23, 10.1016/j.pharmthera.2014.09.003
Moretti, 2003, Affective disorders, antidepressant drugs and brain metabolism, Molecular Psychiatry, 8, 773, 10.1038/sj.mp.4001353
Mortensen, 2015, Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients, Expert Opinion on Drug Safety, 14, 911, 10.1517/14740338.2015.1033396
Mortensen, 2015, Early antidepressant treatment and all-cause 30-day mortality in patients with ischemic stroke, Cerebrovascular Diseases, 40, 81, 10.1159/000435819
Mortensen, 2013, Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke. A nationwide propensity score-matched follow-up study, Stroke, 44, 420, 10.1161/STROKEAHA.112.674242
Mortensen, 2014, Impact of prestroke selective serotonin reuptake inhibitor treatment on stroke severity and mortality, Stroke, 45, 2121, 10.1161/STROKEAHA.114.005302
Musselman, 1996, Exaggerated platelet reactivity in major depression, The American Journal of Psychiatry, 153, 1313, 10.1176/ajp.153.10.1313
Na, 2014, Efficacy of adjunctive celecoxib treatment for patients with major depressive disorders: A meta-analysis, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 48, 79, 10.1016/j.pnpbp.2013.09.006
Naarding, 2011, Vascular depression: Where do we go from now?, Expert Review of Neurotherapeutics, 11, 77, 10.1586/ern.10.92
Narushima, 2003, A reappraisal of poststroke depression, intra-and inter-hemispheric lesion location using meta-analysis, The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 422, 10.1176/jnp.15.4.422
Ng, 2008, Oxidative stress in psychiatric disorders: Evidence base and therapeutic implications, The International Journal of Neuropsychopharmacology, 11, 851, 10.1017/S1461145707008401
Nguyen, 2016, A pathway proteomic profile of ischemic stroke survivors reveals innate immune dysfunction in association with mild symptoms of depression — A pilot study, Frontiers in Neurology, 7, 85, 10.3389/fneur.2016.00085
Niedermaier, 2004, Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke, The Journal of Clinical Psychiatry, 65, 1619, 10.4088/JCP.v65n1206
Nikisch, 2004, Steroselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: Relationship with 5-HIAA in CSF and clinical response, Journal of Clinical Psychopharmacology, 24, 283, 10.1097/01.jcp.0000125680.89843.a6
Noonan, 2013, Meta-analyses indicate association between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke, Journal of Stroke and Cerebrovascular Diseases, 22, e124, 10.1016/j.jstrokecerebrovasdis.2012.09.008
O'Donnell, 2010, Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study, Lancet, 376, 112, 10.1016/S0140-6736(10)60834-3
O'Keefe, 2014, Social isolation after stroke leads to depressive-like behavior and decreased BDNF levels in mice, Behavioural Brain Research, 260, 162, 10.1016/j.bbr.2013.10.047
Owens, 2001, Second-generation SSRIs: Human monoamine transporter binding profile of escitalopram and R-fluoxetine, Biological Psychiatry, 50, 345, 10.1016/S0006-3223(01)01145-3
Pan, 2012, Bidirectional association between depression and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies, Diabetes Care, 35, 1171, 10.2337/dc11-2055
Pan, 2011, Depression and risk of stroke morbidity and mortality. A meta-analysis and systematic review, JAMA, 306, 1241, 10.1001/jama.2011.1282
Paolucci, 2008, Epidemiology and treatment of post-stroke depression, Neuropsychiatric Disease and Treatment, 4, 145, 10.2147/NDT.S2017
Paolucci, 2017, Advances in antidepressants for treating post-stroke depression, Expert Opinion on Pharmacotherapy, 18, 1011, 10.1080/14656566.2017.1334765
Papakostas, 2007, Are antidepressant drugs that combine serotoninergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorders? A meta analysis of newer agents, Biological Psychiatry, 62, 1217, 10.1016/j.biopsych.2007.03.027
Pastoor, 2014, Clinical pharmacology review of escitalopram for the treatment of depression, Expert Opinion on Drug Metabolism & Toxicology, 10, 121, 10.1517/17425255.2014.863873
Paulzen, 2016, Measuring citalopram in blood and central nervous system: Revealing a distribution pattern that differs from other antidepressants, International Clinical Psychopharmacology, 31, 119, 10.1097/YIC.0000000000000114
Penninx, 2013, Understanding the somatic consequence of depression: Biological mechanisms and the role of depression symptoms profile, BMC Medicine, 11, 129, 10.1186/1741-7015-11-129
Pietra Pedroso, 2016, Biomarkers of post-stroke depression, Current Neurovascular Research, 13, 163, 10.2174/1567202613666160219120114
Provinciali, 2002, Post-stroke and vascular depression: A critical review, Neurological Sciences, 22, 417, 10.1007/s100720200000
Quaranta, 2008, Mood disorders after stroke: Diagnostic validation of the poststroke depression rating scale, Cerebrovascular Diseases, 26, 237, 10.1159/000147450
Queirazza, 2014, Poststroke depression and 5-HTTLPR, Journal of Neurology, Neurosurgery, and Psychiatry, 85, 241, 10.1136/jnnp-2012-304149
Quinn, 2009, Evidence-based stroke rehabilitation: An expanded guidance document from the European Stroke Organisation (ESO) guidelines for the management of ischaemic stroke and transient ischaemic attack 2008, Journal of Rehabilitation Medicine, 41, 99, 10.2340/16501977-0301
Ramasubbu, 2011, Therapy for prevention of post-stroke depression, Expert Opinion on Pharmacotherapy, 12, 2177, 10.1517/14656566.2011.596149
Razmara, 2017, Depression is associated with a high risk of death among stroke survivors, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2017.07.006
Renshaw, 2001, Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression, The American Journal of Psychiatry, 158, 2048, 10.1176/appi.ajp.158.12.2048
Rezin, 2009, Mitochondrial dysfunction and psychiatric disorders, Neurochemical Research, 34, 1021, 10.1007/s11064-008-9865-8
Ried, 2010, Does prestroke depression impact poststroke depression and treatment?, The American Journal of Geriatric Psychiatry, 18, 624, 10.1097/JGP.0b013e3181ca822b
Ried, 2011, Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality, The Annals of Pharmacotherapy, 45, 888, 10.1345/aph.1P478
Robinson, 2003, Poststroke depression: Prevalence, diagnosis, treatment, and disease progression, Biological Psychiatry, 54, 376, 10.1016/S0006-3223(03)00423-2
Robinson, 2016, Post-stroke depression: A review, The American Journal of Psychiatry, 173, 221, 10.1176/appi.ajp.2015.15030363
Robinson, 2008, Escitalopram and problem-solving therapy for prevention of poststroke depression, JAMA, 299, 2391, 10.1001/jama.299.20.2391
Robinson, 1984, Mood disorders in stroke patients. Importance of location of lesions, Brain, 107, 81, 10.1093/brain/107.1.81
Robinson, 2008, Decreased heart rate variability is associated with poststroke depression, The American Journal of Geriatric Psychiatry, 16, 867, 10.1097/JGP.0b013e318180057d
Salaycik, 2007, Depressive symptoms and risk of stroke. The Framingham study, Stroke, 38, 16, 10.1161/01.STR.0000251695.39877.ca
Salter, 2013, Prevention of post-stroke depression: Does prophylactic pharmacotherapy work?, Journal of Stroke and Cerebrovascular Diseases, 22, 1243, 10.1016/j.jstrokecerebrovasdis.2012.03.013
Sanacora, 2012, Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology of mood disorders, Neuropharmacology, 62, 63, 10.1016/j.neuropharm.2011.07.036
Santarelli, 2003, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants, Science, 301, 805, 10.1126/science.1083328
Santos, 2009, The neuroanatomical model of post-stroke depression: Towards a change of focus?, Journal of the Neurological Sciences, 283, 158, 10.1016/j.jns.2009.02.334
Sauer, 2003, Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction, Circulation, 108, 32, 10.1161/01.CIR.0000079172.43229.CD
Schmidt, 2007, The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior, Behavioural Pharmacology, 18, 391, 10.1097/FBP.0b013e3282ee2aa8
Seifert, 2012, Depressive symptoms and the risk of ischemic stroke in the elderly—Influence of age and sex, PLoS One, 7, 10.1371/journal.pone.0050803
Selim, 2012, Poststroke treatment with selective serotonin reuptake inhibitors. A journey from sadness to motor recovery, Stroke, 43, 3154, 10.1161/STROKEAHA.112.657635
Shi, 2017, Risk factors for post-stroke depression: A meta-analysis, Frontiers in Aging Neuroscience, 9, 18, 10.3389/fnagi.2017.00218
Shin, 2009, Fluoxetine and sertraline attenuate postischemic brain injury in mice, The Korean Journal of Physiology and Pharmacology, 13, 257, 10.4196/kjpp.2009.13.3.257
Shin, 2014, Use of selective serotonin reuptake inhibitors and risk of stroke: A systematic review and meta-analysis, Journal of Neurology, 261, 686, 10.1007/s00415-014-7251-9
Sibolt, 2013, Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke, Cerebrovascular Diseases, 36, 336, 10.1159/000355145
Siepmann, 2015, The effects of pretreatment versus de novo treatment with selective serotonin reuptake inhibitors on short-term outcome after acute ischemic stroke, Journal of Stroke and Cerebrovascular Diseases, 24, 1886, 10.1016/j.jstrokecerebrovasdis.2015.04.033
Siepmann, 2015, Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: Possible mechanisms and clinical evidence, Brain and Behavior: A Cognitive Neuroscience Perspective, 5, 10.1002/brb3.373
Song, 2011, Cytokines mediated inflammation and decreased neurogenesis in animal models of depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 760, 10.1016/j.pnpbp.2010.06.020
Spalletta, 2006, The etiology of poststroke depression: A review of the literature and a new hypothesis involving inflammatory cytokines, Molecular Psychiatry, 11, 984, 10.1038/sj.mp.4001879
Spalletta, 2013, Neuropsychiatric symptoms and interleukin-6 levels in acute stroke, The Journal of Neuropsychiatry and Clinical Neurosciences, 25, 255, 10.1176/appi.neuropsych.12120399
Spalletta, 2005, Symptom profile of DSM-IV major and minor depressive disorders in first-ever stroke patients, The American Journal of Geriatric Psychiatry, 13, 108, 10.1097/00019442-200502000-00004
Sugo, 2002, Social stress exacerbates focal cerebral ischemia in mice, Stroke, 33, 1660, 10.1161/01.STR.0000016967.76805.BF
Sun, 2016, Association of major depressive episodes with stroke risk in a prospective study of 0.5 million Chinese adults, Stroke, 47, 2203, 10.1161/STROKEAHA.116.013512
Sun, 2016, Fluoxetine enhances neurogenesis in aged rats with cortical infarcts, but this is not reflected in a behavioral recovery, Journal of Molecular Neuroscience, 58, 233, 10.1007/s12031-015-0662-y
Surtees, 2008, Psychological distress, major depressive disorder, and risk of stroke, Neurology, 70, 788, 10.1212/01.wnl.0000304109.18563.81
Swenson, 2006, Adverse cardiovascular events in antidepressant trials involving high-risk patients: A systematic review of randomized trials, Canadian Journal of Psychiatry, 51, 923, 10.1177/070674370605101408
Szczudlik, 2004, Serum interleukin-6 predicts cortisol release in acute stroke patients, Journal of Endocrinological Investigation, 27, 37, 10.1007/BF03350908
Taylor, 2013, The vascular depression hypothesis: Mechanisms linking vascular disease with depression, Molecular Psychiatry, 18, 963, 10.1038/mp.2013.20
Terroni, 2011, Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: A 4-month prospective study, The World Journal of Biological Psychiatry, 12, 539, 10.3109/15622975.2011.562242
Towfighi, 2017, Poststroke depression. A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 48, e30, 10.1161/STR.0000000000000113
Truelsen, 2006, Stroke incidence and prevalence in Europe: A review of available data, European Journal of Neurology, 13, 581, 10.1111/j.1468-1331.2006.01138.x
Tsai, 2011, Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: A double-blind randomized placebo-controlled trial, International Clinical Psychopharmacology, 26, 263, 10.1097/YIC.0b013e32834a5c64
Villa, 2012, Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing, Neuroscience, 227, 55, 10.1016/j.neuroscience.2012.09.041
Villa, 2017, Mitochondrial energy metabolism of rat hippocampus after desipramine and fluoxetine treatments, Neuropharmacology, 121, 30, 10.1016/j.neuropharm.2017.04.025
Villa, 2016, Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria, Neuroscience, 330, 326, 10.1016/j.neuroscience.2016.05.051
Villa, 2017, Effects of neuroprotectants before and after stroke: Statins and anti-hypertensives, 349
Villa, 2013, Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes, Neurochemistry International, 63, 765, 10.1016/j.neuint.2013.10.004
Vogelzangs, 2012, Association of depressive disorders, depression characteristics and antidepressant medication with inflammation, Translational Psychiatry, 2, 10.1038/tp.2012.8
Wang, 2016, Role of hypothalamic cannabinoid receptors in post-stroke depression in rats, Brain Research Bulletin, 121, 91, 10.1016/j.brainresbull.2016.01.006
Wang, 2010, Involvement of serotonin neurotransmission in hippocampal neurogenesis and behavioral responses in a rat model of post-stroke depression, Pharmacology, Biochemistry, and Behavior, 95, 129, 10.1016/j.pbb.2009.12.017
Wang, 2008, Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress, Behavioural Brain Research, 189, 9, 10.1016/j.bbr.2007.11.028
Wei, 2015, Post-stroke depression and lesion location: A systematic review, Journal of Neurology, 262, 81, 10.1007/s00415-014-7534-1
Werheid, 2016, A two-phase pathogenetic model of depression after stroke, Gerontology, 62, 33, 10.1159/000381876
Williams, 2005, Depression and stroke: Cause or consequence?, Seminars in Neurology, 25, 396, 10.1055/s-2005-923534
Windle, 2005, Fluoxetine and recovery of motor function after focal ischemia in rats, Brain Research, 1044, 25, 10.1016/j.brainres.2005.02.060
Winstein, 2016, Guidelines for adult stroke rehabilitation and recovery: A guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 47, e98, 10.1161/STR.0000000000000098
Xu, 2003, Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2 and Cu/Zn-SOD in rat hippocampus, Neuropsychopharmacology, 28, 53, 10.1038/sj.npp.1300009
Xu, 2016, Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression, Medicine, 95, 10.1097/MD.0000000000005349
Yang, 2011, Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke, International Journal of Geriatric Psychiatry, 26, 495, 10.1002/gps.2552
Yang, 2010, The serum interleukin-18 is a potential marker for development of post-stroke depression, Neurological Research, 32, 340, 10.1179/016164110X12656393665080
Yi, 2010, Fluoxetine for the prophylaxis of post-stroke depression in patients with stroke: A meta-analysis, International Journal of Clinical Practice, 64, 1310, 10.1111/j.1742-1241.2010.02437.x
Yu, 2007, JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction, The Journal of Biological Chemistry, 282, 25940, 10.1074/jbc.M701812200
Zhang, 2013, Prophylactic effects of duloxetine on post-stroke depression symptoms: An open single-blind trial, European Neurology, 69, 336, 10.1159/000345374
Zhang, 2012, Correlation between cognitive impairment and brain-derived neurotrophic factor expression in the hippocampus of post-stroke depression rats, Molecular Medicine Reports, 6, 889, 10.3892/mmr.2012.1009